| |
|
|
|
Marina Bay Sands Resort, 10 Bayfront Avenue, Singapore
May 28-31, 2013
Programs: - 2nd Annual Antibody Engineering Asia -- Creative Engineering, Delivery Technologies and Targeting
- Inaugural Clinical Data Management and eClinical Trials
- Inaugural Molecular Diagnostics
|
|
|
|
|
|
|
|
Organized by:
|
|
Cambridge Healthtech Institute |
|
|
Invited Speakers:
|
|
Speakers Include: - Dana Ault-Riche, Ph.D., CEO, Pharmaceuticals, Reflexion Pharmaceuticals
- Satoshi Banba, Executive Director, Medical & BioTechnology Department, Seed Planning, Inc.
- John Dangerfield, Ph.D., Managing Director, Anovasia Pte Ltd
- Dimiter Dimitrov, Ph.D., Senior Investigator, Center for Cancer Research, National Cancer Institute, NIH
- Bogi Eliasen, Program Director, FarGen, Ministry of Health, Faroe Islands
- Andrew Fellowes, Ph.D., FHGSA, FFSc (RCPA), Scientist in Charge, Molecular Pathology Diagnostic Development, Peter MacCallum Cancer Centre
- Mick Foley, Ph.D., CSO, AdAlta Pty Ltd.
- Samik Ghosh, Ph.D., Senior Scientist, The Systems Biology Institute, Tokyo
- Rui Gong, Ph.D., Professor, Head, Antibody Engineering Group, Wuhan Institute of Virology, Chinese Academy of Sciences, China
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
April 19, 2013
|
|
|
|
|
|
|
|
Registration:
|
|
Register Now
|
|
|
E-mail:
|
|
kwaterman@healthtech.com
|
|
|
|
|
|
|
|
|